DS-4108

N/A

Report date: 2025/01/26 17:21:38
NME

Base Information

Drug NameDS-4108
Drug Alias NameG6PC splicing correction therapy (Daiichi Sankyo)DS-4108
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionGlucose-6-phosphatase modulators
TargetsGlucose-6-phosphatase
Therapy Area/IndicationsGlycogen Storage Disease Type I
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDaiichi Sankyo Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDaiichi Sankyo Co Ltd
Inactive CompaniesN/A
Active IndicationsGlycogen Storage Disease Type I
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A